Clinical trials
5 active studies led by Cellenkos, Inc., of 7 in all
Source: ClinicalTrials.gov, Studies with Cellenkos, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 5Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Cellenkos, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Cellenkos, Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Cellenkos, Inc. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Cellenkos, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Cellenkos, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Cellenkos, Inc. is in.
From our blog
Stories on the topics Cellenkos, Inc. works in.
Patient Support Programmes: Helping Patients Stay on Treatment
WHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
Read
Cord Blood Banking: Is It Worth It?
Doctors' groups such as ACOG support public cord blood donation, but say routine private banking is not…
Read
Biologic Safety Testing: The Quiet Backbone of Drug Making
Every vaccine, antibody and cell therapy must be tested for sterility, purity and viruses before it reaches…
Read